• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.脑啡肽酶的突触前定位有助于小鼠大脑中β淀粉样肽的有效清除。
J Neurosci. 2004 Jan 28;24(4):991-8. doi: 10.1523/JNEUROSCI.4792-03.2004.
2
Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.小鼠脑中的β-淀粉样蛋白降解内肽酶(中性内肽酶):突触和轴突定位与β-淀粉样蛋白病理学呈负相关。
Neurosci Res. 2002 May;43(1):39-56. doi: 10.1016/s0168-0102(02)00015-9.
3
Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice.长期的中性内肽酶基因转移与APP转基因小鼠细胞内β淀粉样蛋白水平降低及行为改善相关。
BMC Neurosci. 2008 Nov 12;9:109. doi: 10.1186/1471-2202-9-109.
4
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.中性内肽酶基因转移可减轻转基因小鼠的人类淀粉样病变。
J Neurosci. 2003 Mar 15;23(6):1992-6. doi: 10.1523/JNEUROSCI.23-06-01992.2003.
5
Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.中性内肽酶过表达可抑制斑块形成,但无法减少人淀粉样前体蛋白转基因小鼠体内致病性β淀粉样寡聚体及相关认知缺陷。
J Neurosci. 2009 Feb 18;29(7):1977-86. doi: 10.1523/JNEUROSCI.2984-08.2009.
6
Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease.在阿尔茨海默病小鼠模型中通过β-分泌酶1逆向转运调控突触淀粉样β蛋白的生成
J Neurosci. 2017 Mar 8;37(10):2639-2655. doi: 10.1523/JNEUROSCI.2851-16.2017. Epub 2017 Feb 3.
7
Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.APP转基因小鼠中β-淀粉样蛋白的蛋白水解增强可预防斑块形成、继发性病理变化和过早死亡。
Neuron. 2003 Dec 18;40(6):1087-93. doi: 10.1016/s0896-6273(03)00787-6.
8
Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.中性内肽酶缺乏会改变阿尔茨海默病5XFAD小鼠模型中的神经病理学和行为表型。
J Alzheimers Dis. 2015;44(4):1291-302. doi: 10.3233/JAD-142463.
9
Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).在突变型淀粉样前体蛋白(APP)转基因模型中,成熟淀粉样β蛋白沉积物的早期形成取决于β淀粉样蛋白1-42(Aβ(1-42))的水平。
J Neurosci Res. 2001 Nov 15;66(4):573-82. doi: 10.1002/jnr.1247.
10
Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.通过通路损伤,淀粉样前体蛋白/早老素1双转基因小鼠中的弥漫性淀粉样蛋白沉积减少,但斑块数量未减少。
Neuroscience. 2003;119(4):1185-97. doi: 10.1016/s0306-4522(03)00215-x.

引用本文的文献

1
The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease.中性内肽酶和胰岛素降解酶在散发性阿尔茨海默病病因学中的作用
J Neurosci. 2025 Jun 4;45(23):e2152242025. doi: 10.1523/JNEUROSCI.2152-24.2025.
2
Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins.利用人诱导多能干细胞来源的小胶质细胞在中枢神经系统中广泛递送疾病修饰蛋白。
Cell Stem Cell. 2025 Jun 5;32(6):914-934.e8. doi: 10.1016/j.stem.2025.03.009. Epub 2025 Apr 14.
3
Comprehensive review on neprilysin (NEP) inhibitors: design, structure-activity relationships, and clinical applications.中性内肽酶(NEP)抑制剂综述:设计、构效关系及临床应用
Front Pharmacol. 2024 Dec 23;15:1501407. doi: 10.3389/fphar.2024.1501407. eCollection 2024.
4
Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders.中性内肽酶介导的β淀粉样蛋白清除及其在神经退行性疾病中的治疗意义
ACS Pharmacol Transl Sci. 2024 Sep 24;7(12):3645-3657. doi: 10.1021/acsptsci.4c00400. eCollection 2024 Dec 13.
5
In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification.用于神经退行性疾病的体内和体外基因治疗:疾病修饰的希望。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7501-7530. doi: 10.1007/s00210-024-03141-4. Epub 2024 May 22.
6
Modelling Alzheimer's disease in a dish: dissecting amyloid-β metabolism in human neurons.在培养皿中模拟阿尔茨海默病:剖析人类神经元中的淀粉样β蛋白代谢
Neuronal Signal. 2024 Jan 11;8(1):NS20230020. doi: 10.1042/NS20230020. eCollection 2024 Jan.
7
Mistranslation-associated perturbations of proteostasis do not promote accumulation of amyloid beta and plaque deposition in aged mouse brain.错译相关的蛋白稳态失调不会促进老年小鼠大脑中淀粉样β和斑块沉积的积累。
Cell Mol Life Sci. 2023 Nov 27;80(12):378. doi: 10.1007/s00018-023-05031-z.
8
Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective.奈普利酶抑制剂与阿尔茨海默病风险:未来展望。
J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17.
9
Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases.大脑和外周淀粉样β清除的进展:对神经退行性疾病的影响
Exp Neurobiol. 2023 Aug 31;32(4):216-246. doi: 10.5607/en23014.
10
Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer's Disease.β淀粉样蛋白/淀粉样前体蛋白诱导的阿尔茨海默病神经元模型中的兴奋性过高和稳态突触可塑性失调
Front Aging Neurosci. 2022 Jul 6;14:946297. doi: 10.3389/fnagi.2022.946297. eCollection 2022.

本文引用的文献

1
Alzheimer's disease, neuropeptides, neuropeptidase, and amyloid-beta peptide metabolism.阿尔茨海默病、神经肽、神经肽酶与β-淀粉样肽代谢
Sci Aging Knowledge Environ. 2003 Jan 22;2003(3):PE1. doi: 10.1126/sageke.2003.3.pe1.
2
Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.大脑中β淀粉样肽水平与体内胰岛素降解酶活性水平呈负相关。
Proc Natl Acad Sci U S A. 2003 May 13;100(10):6221-6. doi: 10.1073/pnas.1031520100. Epub 2003 May 5.
3
Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.中性内肽酶基因转移可减轻转基因小鼠的人类淀粉样病变。
J Neurosci. 2003 Mar 15;23(6):1992-6. doi: 10.1523/JNEUROSCI.23-06-01992.2003.
4
Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.胰岛素降解酶在体内调节胰岛素、β淀粉样蛋白和β淀粉样前体蛋白细胞内结构域的水平。
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4162-7. doi: 10.1073/pnas.0230450100. Epub 2003 Mar 12.
5
Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.人载脂蛋白E对转基因小鼠中阿尔茨海默病样突触和胆碱能缺陷的调节作用取决于亚型、衰老以及β淀粉样肽的过表达,而与斑块形成无关。
J Neurosci. 2002 Dec 15;22(24):10539-48. doi: 10.1523/JNEUROSCI.22-24-10539.2002.
6
Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme.内皮素转换酶缺乏的小鼠中,阿尔茨海默病β-淀粉样肽水平升高。
J Biol Chem. 2003 Jan 24;278(4):2081-4. doi: 10.1074/jbc.C200642200. Epub 2002 Dec 2.
7
Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis.在β淀粉样蛋白病转基因模型中,皮质皮质连接的破坏可减轻终末区域的淀粉样蛋白负担。
J Neurosci. 2002 Nov 15;22(22):9794-9. doi: 10.1523/JNEUROSCI.22-22-09794.2002.
8
Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice.有证据表明,经突触释放的β-淀粉样蛋白会在转基因小鼠海马体中作为细胞外沉积物积累。
J Neurosci. 2002 Nov 15;22(22):9785-93. doi: 10.1523/JNEUROSCI.22-22-09785.2002.
9
Adeno-associated virus vectors for gene transfer to the brain.用于基因转移至大脑的腺相关病毒载体。
Methods. 2002 Oct;28(2):237-47. doi: 10.1016/s1046-2023(02)00228-1.
10
Alzheimer's disease is a synaptic failure.阿尔茨海默病是一种突触功能障碍。
Science. 2002 Oct 25;298(5594):789-91. doi: 10.1126/science.1074069.

脑啡肽酶的突触前定位有助于小鼠大脑中β淀粉样肽的有效清除。

Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain.

作者信息

Iwata Nobuhisa, Mizukami Hiroaki, Shirotani Keiro, Takaki Yoshie, Muramatsu Shin-ichi, Lu Bao, Gerard Norma P, Gerard Craig, Ozawa Keiya, Saido Takaomi C

机构信息

Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama 351-0198, Japan.

出版信息

J Neurosci. 2004 Jan 28;24(4):991-8. doi: 10.1523/JNEUROSCI.4792-03.2004.

DOI:10.1523/JNEUROSCI.4792-03.2004
PMID:14749444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6729819/
Abstract

A local increase in amyloid-beta peptide (Abeta) is closely associated with synaptic dysfunction in the brain in Alzheimer's disease. Here, we report on the catabolic mechanism of Abeta at the presynaptic sites. Neprilysin, an Abeta-degrading enzyme, expressed by recombinant adeno-associated viral vector-mediated gene transfer, was axonally transported to presynaptic sites through afferent projections of neuronal circuits. This gene transfer abolished the increase in Abeta levels in the hippocampal formations of neprilysin-deficient mice and also reduced the increase in young mutant amyloid precursor protein transgenic mice. In the latter case, Abeta levels in the hippocampal formation contralateral to the vector-injected side were also significantly reduced as a result of transport of neprilysin from the ipsilateral side, and in both sides soluble Abeta was degraded more efficiently than insoluble Abeta. Furthermore, amyloid deposition in aged mutant amyloid precursor protein transgenic mice was remarkably decelerated. Thus, presynaptic neprilysin has been demonstrated to degrade Abeta efficiently and to retard development of amyloid pathology.

摘要

在阿尔茨海默病中,β淀粉样肽(Aβ)在局部的增加与大脑中的突触功能障碍密切相关。在此,我们报告Aβ在突触前位点的分解代谢机制。通过重组腺相关病毒载体介导的基因转移表达的Aβ降解酶中性内肽酶,通过神经回路的传入投射被轴突运输到突触前位点。这种基因转移消除了中性内肽酶缺陷小鼠海马结构中Aβ水平的升高,也降低了年轻的突变淀粉样前体蛋白转基因小鼠中Aβ水平的升高。在后一种情况下,由于中性内肽酶从同侧运输,注射载体一侧对侧海马结构中的Aβ水平也显著降低,并且在两侧,可溶性Aβ比不溶性Aβ降解更有效。此外,老年突变淀粉样前体蛋白转基因小鼠中的淀粉样沉积明显减缓。因此,已证明突触前中性内肽酶能有效降解Aβ并延缓淀粉样病理的发展。